Product description
Retatrutide is a novel synthetic peptide engineered as a triple hormone receptor agonist, targeting the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors. It represents the cutting edge of metabolic peptide literature, cited in advanced preclinical research regarding multi-pathway energy balance.
Primary research focus
-
Triple Receptor Agonism
Studied for its simultaneous activation of GIP, GLP-1, and glucagon receptor pathways.
-
Metabolic & Adipose Regulation
Evaluated in research models assessing lipid oxidation, energy expenditure, and caloric homeostasis.
-
Glycemic & Weight Control
Investigated in metabolic syndrome models for glucose-dependent insulin secretion.

